Considerations and recommendations on camouflage in alopecia in Black women.
| Autor: | Taye M; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia., Kamili NA; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia., Aguh C; Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland., Krueger LD; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of women's dermatology [Int J Womens Dermatol] 2023 Oct 04; Vol. 9 (3), pp. e111. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023). |
| DOI: | 10.1097/JW9.0000000000000111 |
| Abstrakt: | Alopecia is among the leading dermatological concerns affecting Black women. For many women, hair is a central component of identity and self-expression, the loss of which can have significant psychosocial effects. Hair camouflage is often utilized to minimize the visibility of hair loss, provide aesthetic benefits, and improve quality of life. The versatility and affordability of hair camouflage allows patients with alopecia to conceal hair loss, increasing self-confidence, and decreasing social stigma. However, hair camouflage practices often involve adhesives, chemicals, and/or high-tension braiding, all of which can exacerbate alopecia. Accordingly, special considerations should be made to protect patients' natural hair from damage while using these styling practices. A better understanding of best practices for some of the most widely used camouflage options-wigs, extensions, topical hair fibers, and micropigmentation-can help clinicians establish rapport with Black women and optimize individually-tailored therapeutic plans during active treatment and end-stage hair loss. Competing Interests: C.A. serves as a consultant for Pfizer, Lilly, Myovant Sciences & Olaplex and receives grant funding from Janssen. L.K. is a speaker for the Academy of Managed Care Pharmacy. The other authors have no conflicts of interest to disclose. (Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of Women’s Dermatologic Society.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|